
    
      PROTOCOL OUTLINE: Patients receive rituximab IV on days 1, 8, 15, and 22. Patients who
      achieve a clinical response lasting over 4 months may receive a second course of rituximab.

      Patients are followed at 5, 6, 8, and 12 weeks, and then at 6 and 9 months.
    
  